佐力药业
(300181)
| 流通市值：78.02亿 | | | 总市值：90.83亿 |
| 流通股本：6.02亿 | | | 总股本：7.01亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,764,138,447 | 897,797,296.94 | 3,040,763,497.87 | 2,279,713,382.85 |
| 营业总成本 | 1,352,533,232.92 | 674,900,714.95 | 2,370,426,574.04 | 1,720,477,214.14 |
| 其他经营收益 | | | | |
| 营业利润 | 447,289,849.12 | 237,996,923.07 | 766,929,828.88 | 617,741,588.5 |
| 利润总额 | 446,671,287.56 | 237,607,239.7 | 755,667,884.66 | 610,760,250.3 |
| 净利润 | 379,262,795.18 | 202,011,621.75 | 642,436,652.8 | 518,111,660.82 |
| 每股收益 | | | | |
| 其他综合收益 | -21,869,814.39 | 38,704,464.72 | 104,850,057.77 | 193,161,979.42 |
| 综合收益总额 | 357,392,980.79 | 240,716,086.47 | 747,286,710.57 | 711,273,640.24 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,523,393,092.95 | 2,598,075,424.91 | 2,391,301,974.43 | 2,380,977,141.98 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,674,795,432.24 | 2,732,627,933.98 | 2,320,368,925.15 | 2,262,328,465.38 |
| 资产总计 | 5,198,188,525.19 | 5,330,703,358.89 | 4,711,670,899.58 | 4,643,305,607.36 |
| 流动负债: | | | | |
| 流动负债合计 | 1,653,524,447.33 | 1,674,897,758.77 | 1,338,957,055.95 | 1,278,802,587.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 160,093,295.79 | 162,443,871.24 | 131,383,541.45 | 181,804,469.12 |
| 负债合计 | 1,813,617,743.12 | 1,837,341,630.01 | 1,470,340,597.4 | 1,460,607,056.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,325,823,314.36 | 3,424,388,588.24 | 3,180,077,388.97 | 3,117,125,872.98 |
| 股东权益合计 | 3,384,570,782.07 | 3,493,361,728.88 | 3,241,330,302.18 | 3,182,698,551.13 |
| 负债和股东权益合计 | 5,198,188,525.19 | 5,330,703,358.89 | 4,711,670,899.58 | 4,643,305,607.36 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,782,309,666.15 | 809,560,228.46 | 3,111,354,396.3 | 2,217,743,303.91 |
| 经营活动现金流出小计 | 1,552,174,103.88 | 729,552,782.1 | 2,699,552,661.38 | 1,951,741,862.19 |
| 经营活动产生的现金流量净额 | 230,135,562.27 | 80,007,446.36 | 411,801,734.92 | 266,001,441.72 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,501,599.43 | 9,279.43 | 3,322,978.58 | 6,073,598 |
| 投资活动现金流出小计 | 139,952,467.81 | 103,830,292.55 | 414,575,320.97 | 235,959,253.8 |
| 投资活动产生的现金流量净额 | -137,450,868.38 | -103,821,013.12 | -411,252,342.39 | -229,885,655.8 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 553,761,514 | 242,018,654 | 883,895,750 | 733,114,250 |
| 筹资活动现金流出小计 | 682,775,154 | 170,926,460.92 | 1,001,104,624.14 | 876,194,801.29 |
| 筹资活动产生的现金流量净额 | -129,013,640 | 71,092,193.08 | -117,208,874.14 | -143,080,551.29 |
| 汇率变动对现金及现金等价物的影响 | -100.57 | -63.35 | -144.48 | -96.54 |
| 现金及现金等价物净增加额 | -36,329,046.68 | 47,278,562.97 | -116,659,626.09 | -106,964,861.91 |
| 期末现金及现金等价物余额 | 622,566,380.37 | 706,173,990.02 | 658,895,427.05 | 668,590,191.23 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -36,329,046.68 | - | -116,659,626.09 | - |
最新报告期：2026-09-11| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中邮证券 | 盛丽华,龙永茂 | 1.12 | 1.36 | 1.58 | 2026-09-11 |
| 开源证券 | 余汝意,巢舒然 | 1.16 | 1.49 | 1.65 | 2026-08-31 |
| 长城证券 | 刘鹏,袁紫馨 | 1.01 | 1.17 | 1.33 | 2026-08-30 |